Pretomanid News
Pretomanid currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Pretomanid with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (XDR), or treatment-intolerant or nonresponsive...
- Evidence level: L5
- Predicted indications (20):
- candidiasis (99.7%)
- leprosy (99.3%)
- coronary artery disease (99.2%)
- myocardial ischemia (99.2%)
- anomalous left coronary artery from the pulmonary artery (99.1%)
- HIV infectious disease (98.8%)
- oral candidiasis (98.7%)
- Bacteroidaceae infectious disease (98.7%)
- thrombocytopenia (98.7%)
- fascioliasis (98.6%)
- acne (disease) (98.6%)
- feline acquired immunodeficiency syndrome (98.5%)
- simian immunodeficiency virus infection (98.5%)
- marcothrombocytopenia with mitral valve insufficiency (98.5%)
- hereditary thrombocytopenia with normal platelets (98.5%)
- opisthorchiasis (98.4%)
- anaerobic bacteria infectious disease (98.4%)
- multiple endocrine neoplasia (98.4%)
- transient neonatal thrombocytopenia (98.4%)
- breast fibrocystic disease (98.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.